Tekla World Healthcare FundTHW -1.17%57 Net Margin % is 111.27% as of Mar. 2026, which is 13% above its 10-year median of 98.39. GuruFocus rates THW with a GF Score™ of 57/100 and a GF Value™ of $19.36 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 1,571 Asset Management companies, Tekla World Healthcare Fund ranks better than 78.29% on this metric.
The historical rank and industry rank for Tekla World Healthcare Fund's Net Margin % or its related term are showing as below:
THW'
s Net Margin % Range Over the Past 10 Years
Min: 94.95 Med: 98.39 Max: 113.33
Current: 99.07
THW's Net Margin % is ranked better than 78.29% of 1571
companies
in the Asset Management industry
Industry Median: 85.3
vs THW: 99.07
Tekla World Healthcare Fund (NYSE:THW) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Tekla World Healthcare Fund Net Margin % Related Terms
Tekla World Healthcare Fund Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, Tekla World Healthcare Fund's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tekla World Healthcare Fund Net Margin % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Tekla World Healthcare Fund's Net Margin % distribution charts can be found below:
* The bar in red indicates where Tekla World Healthcare Fund's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tekla World Healthcare Fund (THW) has a Net Margin % of 111.27% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Tekla World Healthcare Fund and its competitors. This is 13% above median its historical median of 98.39. Over the past decade, Tekla World Healthcare Fund's Net Margin % has ranged from 94.95 to 113.33. According to the industry distribution chart, Tekla World Healthcare Fund ranks #341 out of 1571 companies in the Asset Management industry, placing it in the top 21.7%.
Is Tekla World Healthcare Fund's Net Margin % too high?
Tekla World Healthcare Fund's current Net Margin % of 111.27% is 13% above median its 10-year median of 98.39. Over the past 10 years, this metric has ranged from a low of 94.95 to a high of 113.33. The Asset Management industry median Net Margin % is 85.30. Tekla World Healthcare Fund's value of 111.27% is 30.4% above this industry median. Based on the distribution chart, Tekla World Healthcare Fund ranks #341 out of 1571 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, Tekla World Healthcare Fund has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tekla World Healthcare Fund's Net Margin % compare to MSIF and IQI?
According to the Asset Management industry distribution chart, Tekla World Healthcare Fund ranks #341 out of 1571 companies for Net Margin %. This places Tekla World Healthcare Fund in the top 22% of its industry — outperforming the majority of peers. The industry median Net Margin % is 85.30. Tekla World Healthcare Fund's value of 111.27% is 30.4% above this benchmark. Historically, Tekla World Healthcare Fund's own Net Margin % has ranged from 94.95 to 113.33 over the past decade. While the company's 10-year median is 98.39 vs. the industry median of 85.30, Tekla World Healthcare Fund has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for an Asset Management company?
The median Net Margin % among Asset Management companies is 85.30, based on 1,571 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tekla World Healthcare Fund's current Net Margin % of 111.27% is 30.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Tekla World Healthcare Fund and its competitors. For the Asset Management industry, the median Net Margin % is 85.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tekla World Healthcare Fund's current Net Margin % is 111.27%, which is 13% above median its own 10-year median of 98.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tekla World Healthcare Fund stock overvalued right now?
Based on GuruFocus' analysis, Tekla World Healthcare Fund (THW) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.36, compared to a current price of $13.51 — trading 30.2% below its estimated fair value. The current Net Margin % is 111.27%, which is 13% above median its 10-year median of 98.39 and 30.4% above the Asset Management industry median of 85.30. Tekla World Healthcare Fund's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Tekla World Healthcare Fund (THW), the current Net Margin % is 111.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tekla World Healthcare Fund (THW) Overvalued in 2026?
Based on GuruFocus' analysis, Tekla World Healthcare Fund stock appears to be undervalued.
The current stock price of $13.51 is trading 30.2% below its estimated GF Value™ of $19.36.
GuruFocus considers Tekla World Healthcare Fund to be Significantly Undervalued.
Key valuation signals for THW:
Net Margin %: 111.27% (13% above median its 10-year median of 98.39)
GF Value™: $19.36 vs. price of $13.51 (30.2% below fair value)
Industry Position: 30.4% above the Asset Management median (#341 of 1571)
No single metric tells the full story. See the THW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.
57GF Score
Get the complete analysis for THW
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
THW has been successfully added to your 
